Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Dec;78(3):372–377.

IgG and IgA enhance the chrysotile-induced production of reactive oxygen metabolites by human polymorphonuclear leucocytes.

M Klockars 1, M Hedenborg 1, J Koistinen 1, T Isobe 1
PMCID: PMC1534836  PMID: 2558822

Abstract

Chrysotile asbestos fibres induce a rapid generation of reactive oxygen metabolites by human polymorphonuclear leucocytes (PMNL) in vitro. This effect was markedly enhanced by the presence of 10-200 micrograms/ml of human gammaglobulin, purified polyclonal IgG, and monoclonal IgG and IgA myeloma proteins. Purified monoclonal IgD, IgM, kappa light chain proteins, and secretory IgA inhibited this chrysotile-induced response. No enhancing effect of IgG was observed when quartz dust or opsonized zymosan were used as stimulators of PMNL metabolism. The enhancing effect of IgG was shown to depend on opsonization of the asbestos fibre. We suggest that the IgG and IgA potentiating effect on the asbestos fibre-induced production of tissue-damaging reactive oxygen metabolites by inflammatory cells is dependent on a particle-specific binding of immunoglobulin to the fibre surface, with subsequent Fc receptor-mediated effects on cells. Such an interaction between certain immunoglobulins and asbestos may explain a number of in vivo phenomena in which immunological responses (hypergammaglobulinemia, circulating immune complexes, etc.) have been shown to relate to the progression of pulmonary asbestosis. The differences between various immunoglobulin classes and monoclonal immunoglobulins could represent an individual inflammation-modulating mechanism in the development of acute or chronic pulmonary asbestosis.

Full text

PDF
372

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Babior B. M. Oxidants from phagocytes: agents of defense and destruction. Blood. 1984 Nov;64(5):959–966. [PubMed] [Google Scholar]
  2. Becklake M. R. Asbestos-related diseases of the lung and other organs: their epidemiology and implications for clinical practice. Am Rev Respir Dis. 1976 Jul;114(1):187–227. doi: 10.1164/arrd.1976.114.1.187. [DOI] [PubMed] [Google Scholar]
  3. Becklake M. R. Exposure to asbestos and human disease. N Engl J Med. 1982 Jun 17;306(24):1480–1482. doi: 10.1056/NEJM198206173062409. [DOI] [PubMed] [Google Scholar]
  4. Burnett D. Immunoglobulins in the lung. Thorax. 1986 May;41(5):337–344. doi: 10.1136/thx.41.5.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davis J. M., Bolton R. E., Douglas A. N., Jones A. D., Smith T. Effects of electrostatic charge on the pathogenicity of chrysotile asbestos. Br J Ind Med. 1988 May;45(5):292–299. doi: 10.1136/oem.45.5.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Doll N. J., Stankus R. P., Goldbach S., Salvaggio J. E. In vitro effect of asbestos fibers on polymorphonuclear leukocyte function. Int Arch Allergy Appl Immunol. 1982;68(1):17–21. doi: 10.1159/000233061. [DOI] [PubMed] [Google Scholar]
  7. Fantone J. C., Feltner D. E., Brieland J. K., Ward P. A. Phagocytic cell-derived inflammatory mediators and lung disease. Chest. 1987 Mar;91(3):428–435. doi: 10.1378/chest.91.3.428. [DOI] [PubMed] [Google Scholar]
  8. Fantone J. C., Ward P. A. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol. 1982 Jun;107(3):395–418. [PMC free article] [PubMed] [Google Scholar]
  9. Fine J. M., Steinbuch M. A simple technique for the isolation of monoclonal IgG and IgA. Rev Eur Etud Clin Biol. 1970 Dec;15(10):1115–1121. [PubMed] [Google Scholar]
  10. Hansen K., Mossman B. T. Generation of superoxide (O2-.) from alveolar macrophages exposed to asbestiform and nonfibrous particles. Cancer Res. 1987 Mar 15;47(6):1681–1686. [PubMed] [Google Scholar]
  11. Hedenborg M., Klockars M. Production of reactive oxygen metabolites induced by asbestos fibres in human polymorphonuclear leucocytes. J Clin Pathol. 1987 Oct;40(10):1189–1193. doi: 10.1136/jcp.40.10.1189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Henson P. M., Johnson H. B., Spiegelberg H. L. The release of granule enzymes from human neutrophils stimulated by aggregated immunoglobulins of different classes and subclasses. J Immunol. 1972 Dec;109(6):1182–1192. [PubMed] [Google Scholar]
  13. Isobe T., Osserman E. F. Plasma cell dyscrasia associated with the production of incomplete (?deleted) IgGlambda molecules, gamma heavy chains, and free lambda chains containing carbohydrate: description of the first case. Blood. 1974 Apr;43(4):505–526. [PubMed] [Google Scholar]
  14. Johnston R. B., Jr, Lehmeyer J. E., Guthrie L. A. Generation of superoxide anion and chemiluminescence by human monocytes during phagocytosis and on contact with surface-bound immunoglobulin G. J Exp Med. 1976 Jun 1;143(6):1551–1556. doi: 10.1084/jem.143.6.1551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kagan E., Solomon A., Cochrane J. C., Kuba P., Rocks P. H., Webster I. Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity. Clin Exp Immunol. 1977 May;28(2):268–275. [PMC free article] [PubMed] [Google Scholar]
  16. Lange A., Smolik R., Zatoński W., Szymańska J. Autoantibodies and serum immunoglobulin levels in asbestos workers. Int Arch Arbeitsmed. 1974 Jan 31;32(4):313–325. doi: 10.1007/BF02178970. [DOI] [PubMed] [Google Scholar]
  17. Light W. G., Wei E. T. Surface charge and asbestos toxicity. Nature. 1977 Feb 10;265(5594):537–539. doi: 10.1038/265537a0. [DOI] [PubMed] [Google Scholar]
  18. Magnusson K. E., Stendahl O., Stjernström I., Edebo L. Reduction of phagocytosis, surface hydrophobicity and charge of Salmonella typhimurium 395 MR10 by reaction with secretory IgA (SIgA). Immunology. 1979 Mar;36(3):439–447. [PMC free article] [PubMed] [Google Scholar]
  19. Mestecky J., Russell M. W., Jackson S., Brown T. A. The human IgA system: a reassessment. Clin Immunol Immunopathol. 1986 Jul;40(1):105–114. doi: 10.1016/0090-1229(86)90073-5. [DOI] [PubMed] [Google Scholar]
  20. Nakashima H., Ando M., Sugimoto M., Suga M., Soda K., Araki S. Receptor-mediated O2- release by alveolar macrophages and peripheral blood monocytes from smokers and nonsmokers. Priming and triggering effects of monomeric IgG, concanavalin A, N-formyl-methionyl-leucyl-phenylalanine, phorbol myristate acetate, and cytochalasin D. Am Rev Respir Dis. 1987 Aug;136(2):310–315. doi: 10.1164/ajrccm/136.2.310. [DOI] [PubMed] [Google Scholar]
  21. Shinoda T., Takahashi N., Takayasu T., Okuyama T., Shimizu A. Complete amino acid sequence of the Fc region of a human delta chain. Proc Natl Acad Sci U S A. 1981 Feb;78(2):785–789. doi: 10.1073/pnas.78.2.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Spiegelberg H. L., Lawrence D. A., Henson P. Cytophilic properties of IgA to human neutrophils. Adv Exp Med Biol. 1974;45(0):67–74. doi: 10.1007/978-1-4613-4550-3_8. [DOI] [PubMed] [Google Scholar]
  23. Tamoto K., Koyama J. Superoxide anion production from guinea pig macrophages stimulated with immune complexes of different IgG subclasses. J Biochem. 1980 Jun;87(6):1649–1657. doi: 10.1093/oxfordjournals.jbchem.a132909. [DOI] [PubMed] [Google Scholar]
  24. Turner-Warwick M. Immune reactions in pulmonary fibrosis. Schweiz Med Wochenschr. 1977 Feb 12;107(6):171–175. [PubMed] [Google Scholar]
  25. Turner-Warwick M., Parkes W. R. Circulating rheumatoid and antinuclear factors in asbestos workers. Br Med J. 1970 Aug 29;3(5721):492–495. doi: 10.1136/bmj.3.5721.492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Van Epps D. E., Brown S. L. Inhibition of formylmethionyl-leucyl-phenylalanine-stimulated neutrophil chemiluminescence by human immunoglobulin A paraproteins. Infect Immun. 1981 Dec;34(3):864–870. doi: 10.1128/iai.34.3.864-870.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Van Epps D. E., Reed K., Williams R. C., Jr Suppression of human PMN bactericidal activity by human IgA paraproteins. Cell Immunol. 1978 Mar 15;36(2):363–376. doi: 10.1016/0008-8749(78)90280-0. [DOI] [PubMed] [Google Scholar]
  28. Van Epps D. E., Williams R. C., Jr Suppression of leukocyte chemotaxis by human IgA myeloma components. J Exp Med. 1976 Nov 2;144(5):1227–1242. doi: 10.1084/jem.144.5.1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Zone J. J., Rom W. N. Circulating immune complexes in asbestos workers. Environ Res. 1985 Aug;37(2):383–389. doi: 10.1016/0013-9351(85)90119-7. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES